Gene patent case unlikely to succeed, but raises key issues
My first experience with intellectual property occurred several years ago when I watched a documentary on the patents on the genes BRCA1 and 2. Individuals with
My first experience with intellectual property occurred several years ago when I watched a documentary on the patents on the genes BRCA1 and 2. Individuals with
On March 9, 2009, President Obama signed an executive order removing restrictions on federal funding for research involving embryonic stem cells. Prior to the signing,
Although copyright issues have consumed the spotlight when it comes to Google Books, a recent thread has suggested that this feature may be of great
Stephanie Anderson is a first year J.D. candidate at Osgoode Hall Law School. The United States has long been awaiting Congress to finally agree on
Industry responses to the European Commission (EC) preliminary report on pharmaceutical competition (see the IPilogue blog of Dec. 15, 2008) are becoming available, and criticism
Greg Hagen is an Assistant Professor in the Faculty of Law at the University of Calgary. While James Thomson’s claims to primate embryonic stem cells